Cedars-Sinai Newsroom (Cancer)
Filter by year
2023
September
12,
2023
|
06:30 AM
America/Los_Angeles
Hematologist-oncologist Navid Hafez, MD, MPH, has joined The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, as director of Precision Medicine and Thoracic Oncology. Hafez will focus on clinical research programs to develo...
Read more
September
06,
2023
|
06:30 AM
America/Los_Angeles
Hematologist/oncologist Kevin Scher, MD, MBA, an expert in patient-centric care with more than 10 years of experience on the Cedars-Sinai Cancer faculty, has been appointed medical director of Cedars-Sinai Cancer in Beverly Hills. In his new role, Sc...
Read more
September
05,
2023
|
06:30 AM
America/Los_Angeles
Investigators from the Cedars-Sinai Board of Governors Regenerative Medicine Institute and Cedars-Sinai Cancer have collaborated to co-develop and test a new version of the chemotherapy workhorse doxorubicin. Their study, published in the peer-review...
Read more
August
31,
2023
|
06:30 AM
America/Los_Angeles
Investigators from Cedars-Sinai Cancer found that Black women with a low-risk form of endometrial cancer were less likely than white women with the same cancer to have a hysterectomy, and less likely to survive their cancer. The study, published in t...
Read more
August
18,
2023
|
06:30 AM
America/Los_Angeles
Investigators from The Angeles Clinic and Research Institute, an affiliate of Cedars-Sinai Cancer, have determined that a combination of drugs that act on the immune system in distinct ways improves survival for patients with the deadliest form of sk...
Read more
August
02,
2023
|
06:00 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators are spearheading a project, funded by a five-year, $11.2 million grant from the National Cancer Institute, part of the National Institutes of Health, to advance scientific knowledge of how biological differences betw...
Read more
July
27,
2023
|
06:00 AM
America/Los_Angeles
Niki Patel, MD, a fellowship-trained hematologist-oncologist board certified in internal medicine and medical oncology, has joined the Division of Medical Oncology at Cedars-Sinai Cancer. She is treating patients in Pasadena at Huntington Cancer Cent...
Read more
July
12,
2023
|
06:30 AM
America/Los_Angeles
Gynecologic oncologist Margaret Liang, MD, has joined the Cedars-Sinai Cancer Division of Gynecologic Oncology, providing care and clinical services for patients within the Department of Obstetrics and Gynecology. She also joins as director for the G...
Read more
July
11,
2023
|
13:00 PM
America/Los_Angeles
New research from Cedars-Sinai Cancer investigators could warrant reconsideration of current screening guidelines to include a poorly recognized cause of Lynch syndrome, the most common cause of hereditary colorectal and endometrial cancers. Their st...
Read more
June
22,
2023
|
07:03 AM
America/Los_Angeles
Members of the Los Angeles Rams’ 2023 rookie class visited Cedars-Sinai this week, bringing smiles to patients throughout the medical center and Cedars-Sinai Marina del Rey Hospital.The football players visited pediatric patients in Guerin Children’s...
Read more
June
22,
2023
|
06:30 AM
America/Los_Angeles
Leo Mascarenhas, MD, MS, an internationally recognized pediatric hematologist-oncologist and sarcoma expert, has been appointed director of Pediatric Hematology and Oncology at Cedars-Sinai Guerin Children’s and as medical director of the Sarcoma Pro...
Read more
June
21,
2023
|
08:00 AM
America/Los_Angeles
As men age, some of their cells lose the very thing that makes them biological males—the Y chromosome—and this loss hampers the body’s ability to fight cancer, according to new research from Cedars-Sinai Cancer.The study, published today in the leadi...
Read more
June
14,
2023
|
06:00 AM
America/Los_Angeles
Physicians at Cedars-Sinai Cancer are using a unique chemotherapy delivery system that offers hope to colorectal cancer patients whose disease has spread and who now have inoperable liver tumors. Cedars-Sinai is one of the few centers in the area to ...
Read more
June
12,
2023
|
07:03 AM
America/Los_Angeles
Carlos Rene Valdez is a big fan of the saying “dance like no one’s watching,” but with one modification. An overachiever with a healthy dose of confidence, Valdez enjoys dancing like no one’s watching even when everyone is watching.Valdez’s dance thr...
Read more
May
24,
2023
|
11:00 AM
America/Los_Angeles
Investigators from Cedars-Sinai Cancer, working in collaboration with colleagues in Colorado and the Netherlands, have identified a specific type of bladder cancer most likely to resist first-line treatment. Their study, published today in the peer-r...
Read more
May
11,
2023
|
07:01 AM
America/Los_Angeles
Investigators at Cedars-Sinai Cancer found that fatty liver, a condition closely associated with obesity, promotes the spread of colorectal cancer to the liver. Their study, published today in the peer-reviewed journal Cell Metabolism, details the pr...
Read more
May
02,
2023
|
07:00 AM
America/Los_Angeles
Cedars-Sinai Cancer welcomes Karine Sargsyan, MD, formerly director of one of the world’s largest clinical biobanks, as scientific director of its OncoBiobank. Sargsyan is charged with leading biobank development and creating new strategies for the o...
Read more
April
29,
2023
|
11:30 AM
America/Los_Angeles
Research from Cedars-Sinai Cancer detailing the largest examination to date of prostate cancer in transgender women, as well as treatment options that improve outcomes in patients with recurrent prostate cancer, will be presented during the American ...
Read more
April
18,
2023
|
07:00 AM
America/Los_Angeles
Vitamin D deficiency could be the reason African American men experience more aggressive prostate cancer at a younger age compared with European American men, new research from Cedars-Sinai Cancer suggests. The multi-institutional study, published to...
Read more
April
18,
2023
|
06:30 AM
America/Los_Angeles
Cedars-Sinai Cancer’s commitment to convergent science—the deep melding of computational, physical engineering and biological sciences—is evident throughout its 2023 Annual Report. The newly released report highlights clinical and research experts fr...
Read more
April
12,
2023
|
08:01 AM
America/Los_Angeles
Investigators from Cedars-Sinai Cancer are collaborating on a streamlined clinical trial design in a study called Pragmatica-Lung. This randomized Phase III trial funded by the National Cancer Institute (NCI), part of the National Institutes of Healt...
Read more
April
03,
2023
|
06:00 AM
America/Los_Angeles
A new study by Cedars-Sinai investigators describes how ChatGPT, an artificial intelligence (AI) chatbot, may help improve health outcomes for patients with cirrhosis and liver cancer by providing easy-to-understand information about basic knowledge,...
Read more
March
27,
2023
|
05:00 AM
America/Los_Angeles
Cedars-Sinai has received a gift of more than $140 million—the largest gift in the hospital’s 121-year history—from the estate of longtime supporters Susanne and Ervin Bard. This gift will propel clinical and research innovation in the medical campus...
Read more
March
08,
2023
|
08:00 AM
America/Los_Angeles
New insights into the effects of a hormonal treatment for transgender men, discovered by Cedars-Sinai investigators, could have implications for the treatment of breast cancer. Transgender men who were assigned female at birth and identify today as m...
Read more
February
15,
2023
|
06:00 AM
America/Los_Angeles
Every day for six weeks, Neil Wank, a 26-year Los Angeles Police Department veteran who in December was diagnosed with an aggressive type of brain cancer called glioblastoma, was escorted down the long hallway leading to the Cedars-Sinai Cancer radia...
Read more
February
10,
2023
|
06:05 AM
America/Los_Angeles
In a large-scale nationwide study, investigators from Cedars-Sinai Cancer have confirmed that rates of pancreatic cancer are rising—and are rising faster among younger women, particularly Black women, than among men of the same age. Their work was pu...
Read more
February
02,
2023
|
06:05 AM
America/Los_Angeles
Cedars-Sinai Cancer investigators have developed a new nanotechnology-based test that can detect and profile prostate cancers—even in microscopic amounts. Their work, published in the peer-reviewed journal nanotoday, suggests that this “liquid biopsy...
Read more
January
20,
2023
|
06:00 AM
America/Los_Angeles
In a brightly lit kitchen one recent afternoon, cancer survivors Patricia Rhodes and Evette Knight were part of a group gathered around a convection burner and a sauté pan filled with mushrooms. Cancer dietitian Meghan Laszlo, RD, explained why they ...
Read more
January
17,
2023
|
07:00 AM
America/Los_Angeles
The Stem Cell and Bone Marrow Transplant Program at Cedars-Sinai Cancer was recently recognized with two important hallmarks of quality: official accreditation for CAR T-cell therapy, and a third year in a row ranking among the top adult bone marrow ...
Read more
2022
December
21,
2022
|
06:00 AM
America/Los_Angeles
Less than three years after joining the Cedars-Sinai Cancer faculty, hematologist-oncologists Justin Darrah, MD, and Akil Merchant, MD, are pioneering new research and bringing a new, comprehensive set of treatment options to patients in the recently...
Read more